Actively Recruiting
Investigating the Role of Central Pain Hypersensitivity in Skeletal Muscle Neural Drive, in People With Knee Pain, and in People With Fibromyalgia Syndrome (Pain-Neural Drive)
Led by University of Nottingham · Updated on 2025-12-15
135
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are investigating the role of central pain hypersensitivity and its impact on nerve signaling to skeletal muscles in adults aged 40 years or older. The focus is on people with chronic knee pain, fibromyalgia, and healthy volunteers without chronic pain. The study aims to understand whether changes in nerve signaling relate to physical function and disability in these groups. The study involves two visits to a medical research facility. During the first visit, participants undergo screening, provide consent, and complete questionnaires along with familiarization exercises. The second visit includes detailed sensory testing, muscle electrical activity measurements using electrodes during static muscle contractions, and physical performance tests. A temporary pain stimulus will also be applied during muscle testing to assess its influence on neuromuscular function. Participants will complete questionnaires on pain severity, disability, fatigue, and physical activity. Physical tests include walking, rising from a chair, and balancing. Researchers will measure pain thresholds, muscle motor unit firing characteristics, and physical performance at baseline. The total involvement includes two visits with assessments of pain sensitivity, neuromuscular control, and physical function to explore how chronic pain affects muscle nerve signaling and mobility.
CONDITIONS
Brief Title
Investigating the Role of Central Pain Hypersensitivity in Skeletal Muscle Neural Drive
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults aged 40 years or older
- For knee pain group: history of knee pain with intensity of 4 or higher out of 10 for most days in the past 3 months
- For fibromyalgia group: previous clinical diagnosis of fibromyalgia and pain intensity of 4 or higher out of 10 for most days in the past 3 months
- For control group: pain-free individuals without known osteoarthritis
You will not qualify if you...
- Body mass index greater than 35
- Body weight of 250 kg or higher
- Pregnancy (for women)
- Unable to give consent
- Unable to meet requirements of clinical assessment
- Performed strenuous exercise in past 24 hours before testing
- Consumed alcohol on day of testing
- Consumed caffeine on day of testing
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person) where screening, eligibility assessment, and informed consent occur
Duration - Up to 2 visits over a short period
Participants attend study visits to undergo clinical assessments, questionnaires, and neuromuscular testing including pain sensitivity and muscle contraction measurements.
2 visits (in-person) involving clinical knee assessment, muscle testing familiarisation, pain sensitivity testing, and questionnaires
Trial Site Locations
Total: 1 location
1
University of Nottingham Graduate Entry Medicine and Health, Royal Derby Hospital, Uttoxeter Road, Derby
Derby, Derbyshire, United Kingdom, DE22 3DT
Actively Recruiting
Research Team
B
Ben Lightowler, MSc
S
Stephanie Smith, PhD
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
3
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here